Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Risk-Sharing Drug Rebate Contracts: Do They Live Up To The Hype?

Executive Summary

Manufacturers and payers will continue to work on innovative pricing arrangements, roundtable panelists said, but they are likely to be less complex and resource intensive than many of the risk-sharing contracts announced to date, particularly in Europe.

You may also be interested in...

Hepatitis C Drugs A Good Fit For Outcomes-Based Contracts, McClellan Tells Insurers

The former CMS and FDA head suggested at an AHIP conference that performance-based payments could help pave the way for a new “pricing model” for specialty drugs in the U.S.

Tapping The Value Of Value-Adds: Why The Drug Industry Needs To Monetize Services And Support

In recent years, it has become standard practice for marketers of pharmaceutical and biotechnology products to offer a whole host of wraparound services to bolster the value proposition of their brands. Why not sell them?

Copay Coupons And Providers: Misaligned Incentives Worrisome – Merck’s Galeota

The increasing pressure on payers and providers to curtail rising health care costs should lead drug companies to adjust marketing practices to the new realities, Merck’s Jay Galeota suggested. He pointed to risk-sharing as an area where interests can be aligned.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts